| Literature DB >> 34980081 |
Hisaki Aiba1,2, Nobuyuki Watanabe3,4, Toshiaki Inagaki5, Muneyoshi Fukuoka1,2, Hideki Murakami1,2.
Abstract
BACKGROUND: We aimed to assess the utility of a clinician-reported outcome (the Japanese Orthopedic Association [JOA] hip score) as evaluated by clinicians and physiotherapists. This assessment was made by comparing these scores to those of the JOA hip disease evaluation questionnaire (JHEQ), which is a measurement of patient-reported outcomes after total hip arthroplasty.Entities:
Keywords: Clinician-reported outcome; JHEQ; JOA hips score; Patient-reported outcome; Physiotherapy; Total hip arthroplasty
Mesh:
Year: 2022 PMID: 34980081 PMCID: PMC8725241 DOI: 10.1186/s12891-021-04980-5
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Patients’ characteristics
| Female vs. male | 45 vs. 7 |
|---|---|
| Right vs. left hip surgery | 30 vs. 22 |
| Age (years; mean, standard deviation) | 66.8 ± 8.9 |
| Body mass index (kg/m2; mean, standard deviation) | 23.5 ± 3.4 |
| Operation time (minutes; median, range) | 97.5 (76–168) |
| Total amount of bleeding (mL; median, range) | 250.0 (10–660) |
| Harris Hip scores, preoperatively (points [total 100]; mean, standard deviation) | 54.0 ± 12.0 |
Implants’ information
| Femoral stem | Acetabular components | Number |
|---|---|---|
| Revelation® hip system | FMP® acetabular system | 10 |
| SL-PLUS™ femoral hip system | R3 Acetabular system® | 36 |
| MODULUS® femoral stem | Delta TT cup® | 5 |
| C2® femoral stem | Delta TT cup® | 1 |
Clinician-reported outcome from different observers
| Physicians (median, IQR) | Therapists (median, IQR) | |||
|---|---|---|---|---|
| JOA hip scores (preoperative) | Pain (/40 points) | 10 (10–20) | 20 (10–30) | .003 |
| ROM (/20 points) | 10 (8–12.8) | 14 (12–16 | <.001*1 | |
| Walk (/20 points) | 10 (5–15) | 10 (5–15) | .912 | |
| ADL (/20 points) | 10 (8–12) | 12 (10–14) | <.001 | |
| Total (/100 points) | 46.5 (37.3–57) | 57.0 (41.8–69.0) | <.001*1 | |
| JOA hip scores (12 months, postoperatively) | Pain (/40 points) | 39 (38–40) | 37 (35–40) | .003 |
| ROM (/20 points) | 20 (18–20) | 18 (17–20) | <.001 | |
| Walk (/20 points) | 20 (15–20) | 18 (15–20) | .004 | |
| ADL (/20 points) | 16 (16–19.5) | 18 (14–20) | .614 | |
| Total (/100 points) | 94.0 (90.3–98.0) | 92 (81.8–98.0) | <.001*1 | |
| JOA hip scores (24 months, postoperatively) | Pain (/40 points) | 39 (40–40) | 38 (35–40) | .004 |
| ROM (/20 points) | 20 (20–20) | 19 (17–20) | <.001 | |
| Walk (/20 points) | 20 (15–20) | 20 (15.6–20) | .709 | |
| ADL (/20 points) | 18 (16–20) | 18 (16–20) | .504 | |
| Total (/100 points) | 96.0 (91.0–98.0) | 94.5 (88.0–98.0) | .004*1 |
ADL activities of daily living, JOA Japanese Orthopedics Association, IQR interquartile range, ROM range of motion. All values are presented as medians and IQRs. The differences were evaluated by the Mann–Whitney test. In cases of normal distribution, the differences were evaluated by Student’s t-test. *1, normal distribution
Correlation between the JOA hip and JHEQ scores
| Pre-operation | Median, IQR | Observers | Correlation | ||||
|---|---|---|---|---|---|---|---|
| JOA-pain | JOA-ROM | JOA-walk | JOA-ADL | JOA-total | |||
| JHEQ-pain | 9.0 (6.0–13.8) | Physicians | .46* | .30 | .23 | .42* | .53** |
| Therapists | .60** | .27 | .31 | .40* | .58** | ||
| JHEQ-movement | 5 (2.0–9.0) | Physicians | .29 | .43* | .54** | .57** | .62** |
| Therapists | .50** | .45* | .57** | .68** | .68** | ||
| JHEQ-mental | 12 (7.0–18.8) | Physicians | .26 | .44* | .52** | .47** | .57** |
| Therapists | .46* | .29 | .49** | .50** | .57** | ||
| JHEQ-total | 30.0 (14.0–40.0) | Physicians | .39 | .45* | .49** | .55** | .66** |
| Therapists | .60** | .37 | .52** | .59** | .69** | ||
| Post-operation (24 months) | Median, IQR | Observers | Correlation | ||||
| JOA-pain | JOA-ROM | JOA-walk | JOA-ADL | JOA-total | |||
| JHEQ-pain | 27.0 (22.0–28.0) | Physicians | .32 | .11 | .32 | .42* | .45* |
| Therapists | .39* | .21 | .63** | .60** | .66** | ||
| JHEQ-movement | 18.5 (12.0–24.0) | Physicians | .37 | .19 | .37 | .48** | .54** |
| Therapists | .43* | .45* | .51** | .67** | .71** | ||
| JHEQ-mental | 25.0 (20.3–27.8) | Physicians | .31 | .06 | .44** | .59** | .54** |
| Therapists | .36 | .23 | .66** | .55** | .65** | ||
| JHEQ-total | 67.5 (57.0–78.3) | Physicians | .38* | .10 | .42* | .56** | .57** |
| Therapists | .44** | .35 | .66** | .69** | .76** | ||
ADL activities of daily living, IQR interquartile range, JHEQ Japanese orthopedic association hip disease evaluation questionnaire, JOA Japanese Orthopedics Association, ROM range of motion, *P < .01, ** P < .001. The scatter plots of the distribution of JOA hip scores and JHEQ preoperatively and 24 months after THA in the Supplement 5
Correlation between JOA hip scores and VAS
| Score (median, IQR) | JOA-physicians | JOA-therapists | JHEQ-total | ||
|---|---|---|---|---|---|
| VAS-satisfaction (/100) | Pre-operation | 13 (2–33) | .32 | .44* | .61** |
| Post-operation (12 months) | 95 (83–100) | .44* | .45* | .55** | |
| Post-operation (24 months) | 96.5 (86–100) | .44* | .43* | .71** |
ADL activities of daily living, JHEQ Japanese orthopedic association hip disease evaluation questionnaire, JOA Japanese Orthopedics Association, ROM range of motion, VAS visual analog scales, * P < .01, ** P < .001. The scatter plots of the distribution of JOA hip scores /JHEQ and VAS-satisfaction preoperatively and 24 months after THA in the Supplement 6